Allianz
Insurer
Aviva's leap up the blue-chip index has ignited further market speculation that at least two insurers could be mulling over a possible approach worth 575p a share valuing the insurer at £14.8bn.
22 July 2011
•
1 min read
PMI
The evolution of health insurance is likely to continue, characterised by an increasingly international scope and scientific considerations. Ron Buchan gives his insights
15 July 2011
•
7 min read
